journal article·2012-01

Transfection using hydroxyapatite nanoparticles in the inner ear via an intact round window membrane in chinchilla

Xuewen Wu, Dalian Ding, Haiyan Jiang, Xiaowei Xing, Suping Huang, Hong Liu, Zhedong Chen, Hong Sun

Journal of Nanoparticle Research· Volume 14· Issue 1
Publisher page

Abstract

Hydroxyapatite nanoparticles (nHAT) are known to have excellent biocompatibility, and have attracted increasing attention as new candidates of non-viral vectors for gene therapy. In our previous studies, nHAT carrying a therapeutic gene and a reporter gene were successfully transfected into the spiral ganglion neurons in the inner ear of guinea pigs in vivo as well as in the cultured cell lines, although the transfection efficiencies were never higher than 30%. In this study, the surface modification of nHAT with polyethylenimine (PEI) was made (PEI–nHAT, diameter = 73.09 ± 27.32 nm) and a recombinant plasmid carrying enhanced green fluorescent protein (EGFP) gene and neurotrophin-3 (NT-3) gene was constructed as pEGFPC2–NT3. The PEI modified nHAT and the recombinant plasmid was then connected to form the nHAT-based vector–gene complex (PEI–nHAT–pEGFPC2–NT3). This complex was then placed onto the intact round window membranes of the chinchillas for inner ear transfection. Auditory brainstem response (ABR) was tested to evaluate auditory function. Green fluorescence of EGFP was observed using confocal microscopy 48 h after administering vector–gene complexes. There was no significant threshold shift in tone burst-evoked ABR at any tested frequency. Abundant, condensed green fluorescence was found in dark cells on both sides of the crista and around the macula of the utricle. Scattered EGFP signals were also detected in vestibular hair cells, some Schwann cells in the cochlear spiral ganglion region, some outer pillar cells in the organ of Corti, and a few cells in the stria vascularis. The density of green fluorescence-marked cells was obviously higher in the vestibular dark cell area than in other areas of the inner ear, suggesting that vestibular dark cells may have the ability to actively engulf the nHAT-based vector–gene complexes. Considering the high transfection efficiency in the vestibular system, PEI–nHAT may be a potential vector for gene therapy of inner ear diseases, especially vestibular disorders, and deserves further study.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Hearing, Cochlea, Tinnitus, Genetics · Nerve injury and regeneration

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (67)

Show source-provided references
1. Akinc A, Thomas M, Klibanov AM, Langer R (2005) Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis. J Gene Med 7(5):657–663. doi: 10.1002/jgm.69610.1002/jgm.696 ↗
2. Arai M, Mizuta K, Saito A, Hashimoto Y, Iwasaki S, Watanabe T, Mineta H (2008) Localization of megalin in rat vestibular dark cells and endolymphatic sac epithelial cells. Acta Otolaryngol 128(6):627–633. doi: 10.1080/0001648070166853110.1080/00016480701668531 ↗
3. Baylin SB, Esteller M, Rountree MR, Bachman KE, Schuebel K, Herman JG (2001) Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. Hum Mol Genet 10(7):687–69210.1093/hmg/10.7.687 ↗
4. Borkholder DA (2008) State-of-the-art mechanisms of intracochlear drug delivery. Curr Opin Otolaryngol Head Neck Surg 16(5):472–477. doi: 10.1097/MOO.0b013e32830e20db10.1097/MOO.0b013e32830e20db ↗
5. Brunot C, Ponsonnet L, Lagneau C, Farge P, Picart C, Grosgogeat B (2007) Cytotoxicity of polyethyleneimine (PEI), precursor base layer of polyelectrolyte multilayer films. Biomaterials 28(4):632–640. doi: 10.1016/j.biomaterials.2006.09.02610.1016/j.biomaterials.2006.09.026 ↗
6. Chen GD, Kermany MH, D’Elia A, Ralli M, Tanaka C, Bielefeld EC, Ding D, Henderson D, Salvi R (2010) Too much of a good thing: long-term treatment with salicylate strengthens outer hair cell function but impairs auditory neural activity. Hear Res 265(1–2):63–69. doi: 10.1016/j.heares.2010.02.01010.1016/j.heares.2010.02.010 ↗
7. Chithrani BD, Ghazani AA, Chan WC (2006) Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett 6(4):662–668. doi: 10.1021/nl052396o10.1021/nl052396o ↗
8. Christensen EI, Birn H (2002) Megalin and cubilin: multifunctional endocytic receptors. Nat Rev Mol Cell Biol 3(4):256–266. doi: 10.1038/nrm77810.1038/nrm778 ↗
9. Dickman JD, Huss D, Lowe M (2004) Morphometry of otoconia in the utricle and saccule of developing Japanese quail. Hear Res 188(1–2):89–103. doi: 10.1016/S0378-5955(03)00377-010.1016/S0378-5955(03)00377-0 ↗
10. Ding D, lI M, Jiang S, Salvi JR (2001) Morphology of inner ear. Heilongjiang Science and Technology Press, Haerbin, pp 24–34
11. Ding D, Jiang T, Qi W, Qu Y, Salvi JR (2010) Science of the inner ear. Chinese Science and Technology Press, Beijing, pp 54–55
12. Fischer D, Bieber T, Li Y, Elsasser HP, Kissel T (1999) A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfection efficiency and cytotoxicity. Pharm Res 16(8):1273–127910.1023/A:1014861900478 ↗
13. Ge X, Jackson RL, Liu J, Harper EA, Hoffer ME, Wassel RA, Dormer KJ, Kopke RD, Balough BJ (2007) Distribution of PLGA nanoparticles in chinchilla cochleae. Otolaryngol Head Neck Surg 137(4):619–623. doi: 10.1016/j.otohns.2007.04.01310.1016/j.otohns.2007.04.013 ↗
14. Hama H, Saito A, Takeda T, Tanuma A, Xie Y, Sato K, Kazama JJ, Gejyo F (2004) Evidence indicating that renal tubular metabolism of leptin is mediated by megalin but not by the leptin receptors. Endocrinology 145(8):3935–3940. doi: 10.1210/en.2004-007410.1210/en.2004-0074 ↗
15. Han Y, Wang X, Li S (2009) A simple route to prepare stable hydroxyapatite nanoparticles suspension. J Nanopart Res 11(5):1235–1240. doi: 10.1007/s11051-008-9507-810.1007/s11051-008-9507-8 ↗
16. Harada Y, Sugimoto Y (1977) Metabolic disorder of otoconia after streptomycin intoxication. Acta Otolaryngol 84(1–2):65–7110.3109/00016487709123943 ↗
17. Hu J, Liu ZS, Tang SL, He YM (2007) Effect of hydroxyapatite nanoparticles on the growth and p53/c-myc protein expression of implanted hepatic vx2 tumor in rabbits by intravenous injection. World J Gastroenterol 13(20):2798–280210.3748/wjg.v13.i20.2798 ↗
18. Hu C, Peng Q, Chen F, Zhong Z, Zhuo R (2010) Low molecular weight polyethylenimine conjugated gold nanoparticles as efficient gene vectors. Bioconjug Chem 21(5):836–843. doi: 10.1021/bc900374d10.1021/bc900374d ↗
19. Hunter-Duvar IM (1983) An electron microscopic study of the vestibular sensory epithelium. Acta Otolaryngol 95(5–6):494–50710.3109/00016488309139434 ↗
20. Husseman J, Raphael Y (2009) Gene therapy in the inner ear using adenovirus vectors. Adv Otorhinolaryngol 66:37–51. doi: 10.1159/000218206
21. Iizuka T, Kanzaki S, Mochizuki H, Inoshita A, Narui Y, Furukawa M, Kusunoki T, Saji M, Ogawa K, Ikeda K (2008) Noninvasive in vivo delivery of transgene via adeno-associated virus into supporting cells of the neonatal mouse cochlea. Hum Gene Ther 19(4):384–390. doi: 10.1089/hum.2007.16710.1089/hum.2007.167 ↗
22. Jero J, Mhatre AN, Tseng CJ, Stern RE, Coling DE, Goldstein JA, Hong K, Zheng WW, Hoque AT, Lalwani AK (2001) Cochlear gene delivery through an intact round window membrane in mouse. Hum Gene Ther 12(5):539–548. doi: 10.1089/10430340130004246510.1089/104303401300042465 ↗
23. Jiang M, Zhang YQ, He GX, Sun H (2007) Protective effect of nt-3 gene mediated by hydroxyapatite nanoparticle on the cochlea of guinea pigs injured by excitotoxicity. Zhong Nan Da Xue Xue Bao Yi Xue Ban 32(4):563–567. doi: 1672-7347(2007)04-0563-05
24. Kawamata S, Harada Y, Tagashira N (1986) Electron-microscopic study of the vestibular dark cells in the crista ampullaris of the guinea pig. Acta Otolaryngol 102(3–4):168–17410.3109/00016488609108662 ↗
25. Khalil IA, Kogure K, Akita H, Harashima H (2006) Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery. Pharmacol Rev 58(1):32–45. doi: 10.1124/pr.58.1.810.1124/pr.58.1.8 ↗
26. Kimura RS (1969) Distribution, structure, and function of dark cells in the vestibular labyrinth. Ann Otol Rhinol Laryngol 78(3):542–56110.1177/000348946907800311 ↗
27. Kraus KS, Ding D, Zhou Y, Salvi RJ (2009) Central auditory plasticity after carboplatin-induced unilateral inner ear damage in the chinchilla: up-regulation of gap-43 in the ventral cochlear nucleus. Hear Res 255(1–2):33–43. doi: 10.1016/j.heares.2009.05.00110.1016/j.heares.2009.05.001 ↗
28. Kren BT, Chowdhury NR, Chowdhury JR, Steer CJ (2002) Gene therapy as an alternative to liver transplantation. Liver Transpl 8(12):1089–1108. doi: 10.1053/jlts.2002.3684410.1053/jlts.2002.36844 ↗
29. Labat-Moleur F, Steffan AM, Brisson C, Perron H, Feugeas O, Furstenberger P, Oberling F, Brambilla E, Behr JP (1996) An electron microscopy study into the mechanism of gene transfer with lipopolyamines. Gene Ther 3(11):1010–1017
30. Lappalainen K, Jaaskelainen I, Syrjanen K, Urtti A, Syrjanen S (1994) Comparison of cell proliferation and toxicity assays using two cationic liposomes. Pharm Res 11(8):1127–113110.1023/A:1018932714745 ↗
31. Li S, Huang L (2000) Nonviral gene therapy: promises and challenges. Gene Ther 7(1):31–34. doi: 10.1038/sj.gt.330111010.1038/sj.gt.3301110 ↗
32. Li GP, Chen XP, Huang ZY (2008) Hydroxyapatite nanoparticles enhance the efficacy of liposome-mediated gene-transfection into HepG2 cells and its mechanisms. Zhonghua Zhong Liu Za Zhi 30(2):111–112
33. Maeda Y, Fukushima K, Kawasaki A, Nishizaki K, Smith RJ (2007) Cochlear expression of a dominant-negative GJB2R75W construct delivered through the round window membrane in mice. Neurosci Res 58(3):250–254. doi: 10.1016/j.neures.2007.03.00610.1016/j.neures.2007.03.006 ↗
34. Mann S, Parker SB, Ross MD, Skarnulis AJ, Williams RJ (1983) The ultrastructure of the calcium carbonate balance organs of the inner ear: an ultra-high resolution electron microscopy study. Proc R Soc Lond B 218(1213):415–42410.1098/rspb.1983.0048 ↗
35. Moghimi SM, Symonds P, Murray JC, Hunter AC, Debska G, Szewczyk A (2005) A two-stage poly(ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy. Mol Ther 11(6):990–995. doi: 10.1016/j.ymthe.2005.02.01010.1016/j.ymthe.2005.02.010 ↗
36. Morris VB, Sharma CP (2010) Folate mediated in vitro targeting of depolymerised trimethylated chitosan having arginine functionality. J Colloid Interface Sci 348(2):360–368. doi: 10.1016/j.jcis.2010.04.09010.1016/j.jcis.2010.04.090 ↗
37. Muller K, Heller H, Doerfler W (2001) Foreign DNA integration. Genome-wide perturbations of methylation and transcription in the recipient genomes. J Biol Chem 276(17):14271–14278. doi: 10.1074/jbc.M00938020010.1074/jbc.M009380200 ↗
38. Nie H, Wang CH (2007) Fabrication and characterization of PLGA/HAp composite scaffolds for delivery of BMP-2 plasmid DNA. J Control Release 120(1–2):111–121. doi: 10.1016/j.jconrel.2007.03.01810.1016/j.jconrel.2007.03.018 ↗
39. Nie C, Liu C, Chen G, Dai J, Li H, Shuai X (2010) Hepatocyte-targeted psiRNA delivery mediated by galactosylated poly(ethylene glycol)-graft-polyethylenimine in vitro. J Biomater Appl. doi: 10.1177/0885328210364678
40. Oh YK, Kim JP, Yoon H, Kim JM, Yang JS, Kim CK (2001) Prolonged organ retention and safety of plasmid DNA administered in polyethylenimine complexes. Gene Ther 8(20):1587–1592. doi: 10.1038/sj.gt.330151610.1038/sj.gt.3301516 ↗
41. Ong HT, Loo JSC, Boey FYC, Russell SJ, Ma J, Peng K-W (2008) Exploiting the high-affinity phosphonate–hydroxyapatite nanoparticle interaction for delivery of radiation and drugs. J Nanopart Res 10(1):141–150. doi: 10.1007/s11051-007-9239-110.1007/s11051-007-9239-1 ↗
42. Park IY, Kim IY, Yoo MK, Choi YJ, Cho MH, Cho CS (2008) Mannosylated polyethylenimine coupled mesoporous silica nanoparticles for receptor-mediated gene delivery. Int J Pharm 359(1–2):280–287. doi: 10.1016/j.ijpharm.2008.04.01010.1016/j.ijpharm.2008.04.010 ↗
43. Pote KG, Ross MD (1991) Each otoconia polymorph has a protein unique to that polymorph. Comp Biochem Physiol B 98(2–3):287–29510.1016/0305-0491(91)90181-C ↗
44. Praetorius M, Brunner C, Lehnert B, Klingmann C, Schmidt H, Staecker H, Schick B (2007) Transsynaptic delivery of nanoparticles to the central auditory nervous system. Acta Otolaryngol 127(5):486–490. doi: 10.1080/0001648060089510210.1080/00016480600895102 ↗
45. Praetorius M, Pfannenstiel S, Klingmann C, Baumann I, Plinkert PK, Staecker H (2008) Expression patterns of non-viral transfection with gfp in the organ of corti in vitro and in vivo. Gene therapy of the inner ear with non-viral vectors. HNO 56(5):524–529. doi: 10.1007/s00106-008-1738-610.1007/s00106-008-1738-6 ↗
46. Santini V, Kantarjian HM, Issa JP (2001) Changes in DNA methylation in neoplasia: pathophysiology and therapeutic implications. Ann Intern Med 134(7):573–586. doi: 200104030-0001110.7326/0003-4819-134-7-200104030-00011 ↗
47. Singh S, Kumar A, Karakoti A, Seal S, Self WT (2010) Unveiling the mechanism of uptake and sub-cellular distribution of cerium oxide nanoparticles. Mol Biosyst 6(10):1813–1820. doi: 10.1039/c0mb00014k10.1039/c0mb00014k ↗
48. Smith TA, Mehaffey MG, Kayda DB, Saunders JM, Yei S, Trapnell BC, McClelland A, Kaleko M (1993) Adenovirus mediated expression of therapeutic plasma levels of human factor ix in mice. Nat Genet 5(4):397–402. doi: 10.1038/ng1293-39710.1038/ng1293-397 ↗
49. Staecker H, Li D, O’Malley BW Jr, Van De Water TR (2001) Gene expression in the mammalian cochlea: a study of multiple vector systems. Acta Otolaryngol 121(2):157–16310.1080/000164801300043307 ↗
50. Sugawara A, Nishiyama M, Chow LCT S (1990) A new biocompatible material calcium phosphate—biomedical applications. Tokyo Shika Ishikai Zashi 38:348–354
51. Sun H, Jiang M, Li G, Zhu S (2006) Neurotrophin-3 gene transfection of cochlear cells with hydroxyapatite nanoparticle vector. Abstr Assoc Res Otolaryngol 29:92
52. Sun H, Jiang M, Zhu SH (2008) In vitro and in vivo studies on hydroxyapatite nanoparticles as a novel vector for inner ear gene therapy. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 43(1):51–57
53. Sun H, Huang A, Cao S (2011) Current status and prospects of gene therapy for the inner ear. Hum Gene Ther. doi: 10.1089/hum.2010.1246.10.1089/hum.2010.246
54. Tamura T, Kita T, Nakagawa T, Endo T, Kim TS, Ishihara T, Mizushima Y, Higaki M, Ito J (2005) Drug delivery to the cochlea using PLGA nanoparticles. Laryngoscope 115(11):2000–2005. doi: 10.1097/01.mlg.0000180174.81036.5a10.1097/01.mlg.0000180174.81036.5a ↗
55. Tan K, Cheang P, Ho IA, Lam PY, Hui KM (2007) Nanosized bioceramic particles could function as efficient gene delivery vehicles with target specificity for the spleen. Gene Ther 14(10):828–835. doi: 10.1038/sj.gt.330293710.1038/sj.gt.3302937 ↗
56. Tan BT, Foong KH, Lee MM, Ruan R (2008) Polyethylenimine-mediated cochlear gene transfer in guinea pigs. Arch Otolaryngol Head Neck Surg 134(8):884–891. doi: 10.1001/archotol.134.8.88410.1001/archotol.134.8.884 ↗
57. Taura A, Taura K, Choung YH, Masuda M, Pak K, Chavez E, Ryan AF (2010) Histone deacetylase inhibition enhances adenoviral vector transduction in inner ear tissue. Neuroscience 166(4):1185–1193. doi: 10.1016/j.neuroscience.2009.12.06410.1016/j.neuroscience.2009.12.064 ↗
58. Tauris J, Christensen EI, Nykjaer A, Jacobsen C, Petersen CM, Ovesen T (2009) Cubilin and megalin co-localize in the neonatal inner ear. Audiol Neurootol 14(4):267–278. doi: 10.1159/00019944610.1159/000199446 ↗
59. Wu XH, Sun H, Xing XW, Huang LH, Huang SP (2010a) Surface modification and DNA-binding assessment of nano-hydroxyapatite. Nan Fang Yi Ke Da Xue Xue Bao 30(10):2233–2236, 2241
60. Wu XW, Ding DL, Sun H, Sun W, Salvi R (2010b) Preparation and analysis of graphics mode of auditory evoked potentials. Chin J Ophthalmol Otorhinolaryngol 10(5):345–349
61. Xie G, Sun J, Zhong G, Liu C, Wei J (2010) Hydroxyapatite nanoparticles as a controlled-release carrier of BMP-2: absorption and release kinetics in vitro. J Mater Sci Mater Med 21(6):1875–1880. doi: 10.1007/s10856-010-4038-010.1007/s10856-010-4038-0 ↗
62. Xing X, He X, Peng J, Wang K, Tan W (2005) Uptake of silica-coated nanoparticles by hela cells. J Nanosci Nanotechnol 5(10):1688–169310.1166/jnn.2005.199 ↗
63. Yang Y, Nunes FA, Berencsi K, Furth EE, Gonczol E, Wilson JM (1994) Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci USA 91(10):4407–441110.1073/pnas.91.10.4407 ↗
64. Zhang W, Pan S, Wen Y, Luo X, Zhang X (2010) Synthesis of poly(ethylene glycol)-g-chitosan-g-poly(ethylene imine) co-polymer and in vitro study of its suitability as a gene-delivery vector. J Biomater Sci Polym Ed 21(6):741–758. doi: 10.1163/156856209X43794110.1163/156856209X437941 ↗
65. Zhu S, Huang B, Zhou K, Huang S, Liu F, Li Y, Xue Z, Long Z (2004) Hydroxyapatite nanoparticles as a novel gene carrier. J Nanopart Res 6:307–311. doi: 10.1023/B:NANO.0000034721.06473.2310.1023/B:NANO.0000034721.06473.23 ↗
66. Zou J, Saulnier P, Perrier T, Zhang Y, Manninen T, Toppila E, Pyykko I (2008) Distribution of lipid nanocapsules in different cochlear cell populations after round window membrane permeation. J Biomed Mater Res B 87(1):10–18. doi: 10.1002/jbm.b.3105810.1002/jbm.b.31058 ↗
67. Zuhorn IS, Kalicharan R, Hoekstra D (2002) Lipoplex-mediated transfection of mammalian cells occurs through the cholesterol-dependent clathrin-mediated pathway of endocytosis. J Biol Chem 277(20):18021–18028. doi: 10.1074/jbc.M11125720010.1074/jbc.M111257200 ↗